Corcept Therapeutics Incorporated - Common Stock — Quarterly Financial Statistics (NASDAQ:CORT) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities 5.13 M44.3 M54.48 M38.45 M-16.77 M 120.45 M Cash from investing activities -3.17 M70.13 M14.64 M-11.84 M4.54 M 77.47 M Cash from financing activities -39.8 M-102.93 M-46.41 M-31.22 M760 K -179.8 M Free cash flow 5.13 M44.3 M54.48 M38.45 M-16.77 M 120.45 M

News

Corcept Therapeutics: Recent Relacorilant Rejection Aside, A Good News Story

Corcept Resubmits NDA for Relacorilant in Cushing's Syndrome

CORT Stock Rises 42% in a Month: Here's What You Should Know

Why Is United Therapeutics (UTHR) Down 3.8% Since Last Earnings Report?

CORT to Resubmit NDA for Relacorilant in Cushing's Syndrome, Stock Up

Wall Street Analysts Believe Corcept (CORT) Could Rally 43.32%: Here's is How to Trade

Will Korlym Continue to Aid CORT's Growth in 2026 After a Strong Q1?

S&P 500 and Nasdaq 100 Post New Record Highs on Chip Stock Strength

Chip Stock Strength Lifts the Broader Market

Stocks Pressured by Signs of Resurgent Inflation

Corcept: 'Strong Buy' On Lifyorli FDA Approval And ALS Phase 3 Advancement (NASDAQ:CORT)

CORT Q1 Earnings Match Estimates, Revenues Miss, 2026 Outlook Raised